TMX Logo Newsfile
Français

Wall Street Wire

Wall Street Wire, is a content and media technology platform that connects the market with under-the-radar companies and sectors. The platform operates a network of industry-focused media channels spanning finance, biopharma, cyber, AI, defense, and additional sectors, delivering insights on both broader market developments and emerging or overlooked companies.

Recent News

StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data

New report covers Nuvectis Pharma (NASDAQ: NVCT) as the company transitions from a single-drug oncology story into a late-stage rare-disease player following its June licensing deal with Haisco Pharmaceutical Group. Report highlights: Nuvectis Pharma (NASDAQ: NVCT) recently secured worldwide rights outside China to NXP100, a potentially best-in-class once-daily oral therapy for paroxysmal nocturnal hemoglobinuria (PNH), along with oncology asset NXP200, from Haisco Pharmaceutical Group. The...

2026-07-14 10:40 AM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us